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Dengue–malaria co-infection reports are scarce. Of 
1,723 consecutive febrile patients in Cayenne Hospital, 238 
had dengue (174 early dengue fever cases) and 393 had 
malaria (371 acute malaria); 17 had both. Diagnosis of 1 of 
these 2 infections should not rule out testing for the other 
infection.  
D
espite a wide overlap between malaria- and dengue-
endemic areas, published reports of co-infections are 
scarce in the literature. The ﬁ  rst 2 patients with concurrent 
malaria (Plasmodium falciparum) and dengue were identi-
ﬁ  ed in July 2005 (1) and November 2006 (P. vivax) (2). 
Since then, a few publications described proven or suspect-
ed associations, but always as isolated cases (3–6).
In French Guiana, a French territory in South America 
that is 92% covered by Amazon rain forest, malaria and 
dengue fever represent 2 major public health concerns. 
The annual number of P. falciparum and P. vivax malaria 
cases ranges from 3,500 to 4,500. In addition, all 4 dengue 
virus serotypes have been isolated in the country (7). To 
determine the frequency of concurrent infection with den-
gue and malaria in French Guiana, we conducted a 1-year 
study of patients evaluated in the emergency department of 
Cayenne Hospital. 
The Study
We carried out a retrospective study by testing blood 
and serum samples on 1,740 patients who consulted the 
emergency department of Cayenne Hospital seeking treat-
ment for fever compatible with malaria and/or dengue dur-
ing a 1-year period, July 2004–June 2005 (Figure). Diag-
nosis of malaria has always been quick; dengue diagnosis 
was initially conducted only in malaria-negative patients. 
In our study, dengue investigations were conducted retro-
spectively at the Pasteur Institute of French Guiana for 99% 
of patients (1,723/1,740) by using serum samples obtained 
at admission and frozen at –80°C. Medical records of case-
patients with dengue–malaria co-infections were consulted 
retrospectively to look for severe or abnormal features.
Malaria diagnosis was based on the identiﬁ  cation of 
hematozoa on a thin blood ﬁ  lm and/or on a thick blood 
ﬁ  lm stained with Giemsa. The screening sensitivity was 
≈6 plasmodia/μL (1/1,000 leukocytes). The asexual 
parasite load (PL) was quantiﬁ  ed in percent parasitized 
erythrocytes for values >0.1 %. For lower values, classes 
were created using thick smears: class 1, <0.00125% but 
positive; class 2, >0.00125% but <0.0125%; and class 3, 
>0.0125% but <0.125%. Asymptomatic Plasmodium spp. 
carriage was considered for classes 1 and 2 (in the absence 
of prior antimalarial treatment and for case-patients resid-
ing >1 year in an area of malaria transmission). Virus iso-
lation or reverse transcription–PCR (RT-PCR) according 
to Lanciotti et al. (8) was performed on all serum samples 
obtained during the acute phase of infection, between day 
0 and day 4 (n = 264). For malaria-positive samples, virus 
isolation was conducted on all samples without a date of 
onset of disease (n = 163). 
Serologic immunoglobulin (Ig) M testing was per-
formed on all serum samples (n = 1,723). Dengue was 
detected in 238 case-patients (13.8%); among these, 73% 
(174/238) were conﬁ  rmed by positive virologic diagnosis 
(isolation or RT-PCR), whereas 27% were probable den-
gue cases (positive IgM serology only). The ﬁ  rst group was 
named early dengue cases (EDC) and the second group late 
dengue cases (LDC). 
Of the 1,723 patients, 393 (22.8%) had smear-positive 
malaria; of those, 251 (63.9%) were P. vivax, 133 (33.8%) 
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Figure. Comparison of conﬁ   rmed cases of dengue fever and 
of symptomatic malaria in patients examined at the emergency 
department of Cayenne Hospital, Cayenne, French Guiana, January 
2004–March 2006. The black frame corresponds to the period of 
the retrospective study (July 2004–June 2005). *Cases conﬁ  rmed 
by positive test results from reverse transcription–PCR or virus 
isolation (Pasteur Institute, Cayenne). †Cases diagnosed based on 
recorded fever or history of fever in the previous 24 h associated 
with microscopic detection of asexual forms of Plasmodium spp. by 
blood smear. Concurrent Dengue and Malaria, French Guiana
were P. falciparum, 2 were P. malariae, and 7 were mixed 
P. vivax and P. falciparum. Most malaria-positive case-pa-
tients had a parasite count above class 2 (371/393 [94.4 %]), 
indicating acute malaria.
Concurrent dengue (EDC and LDC) and malaria were 
conﬁ  rmed in 17 of the 1,723 patients (1%), corresponding 
to 7.1% (17/238) of dengue cases and 4.1% (16/393) of ma-
laria cases, respectively (Table). When considering acute 
malaria associated with EDC, the percentages of conﬁ  rmed 
associations were 3.4% for dengue (6/174, 95% conﬁ  dence 
interval [CI] 0.7–6.2) and 1.6% for malaria (6/371, 95% 
CI 0.3–2.9). All 17 associations were considered clinically 
as malaria, including the 2 case-patients with low parasite 
counts. Antimalarial drugs were administered promptly 
in every case. Dengue serology and virology reports were 
available after the initial episode; however, these results did 
not inﬂ  uence patient management. Among the 6 acute con-
current infections, none was severe. The clinical evolution 
was always favorable. Three patients were hospitalized, all 
in the IgM-seropositive group, i.e., LDC; only 1 was severe-
ly ill. This patient, who had P. vivax malaria infection, was 
hospitalized for interstitial pneumonia with severe anemia. 
Intubation, blood transfusion, and antimicrobial drugs were 
required, but he was discharged from the intensive care unit 
after 11 days. No causative agent was identiﬁ  ed for this pneu-
monia. The second patient was hospitalized for diabetes, 
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Table. Clinical course and diagnosis in 17 case-patients with confirmed or suspected concurrent dengue and malaria, Cayenne 
Hospital, Cayenne, French Guiana, July 2004–June 2005* 
Malaria diagnosis Dengue diagnosis
Parasitemia
Patient
no./birth
year Species % Class Hospitalized†
Initial diagnosis 
and clinical signs IgM RT-PCR Iso Conclusion
1/1983 Pv <0.1 C3 No Malaria – + DEN-1 ND Confirmed acute 
concurrent disease
2/1984 Pv 0.15 C4 No Malaria, Tp 
51,000
–  + DEN-3 ND Confirmed acute 
concurrent disease
3/1973 Pv 0.8 C4 No Malaria –  + DEN-3 ND Confirmed acute 
concurrent disease
4/1975 Pf 0.1 C3 No Malaria –  + DEN-3 ND Confirmed acute 
concurrent disease
5/1983 Pv 0.1 C3 No Malaria –  + DEN-3 ND Confirmed acute 
concurrent disease
6/1980 Pv 0.2 C4 No Malaria, Tp 
52,000, Hb 9.4
SeroC – ND Confirmed acute 
concurrent disease
7/1981 Pf <0.1 C1 No Malaria‡ – ND DEN-3 Confirmed concurrent 
infection
8/1953 Pv <0.1 C3 Yes§ Malaria, Tp 
71,000
+ – – Suspected concurrent 
infection
9/1952 Pv 0.8 C4 No Malaria, Tp 
30,000, BP 80/50
+  – – Suspected concurrent 
infection
10/1948 Pv 0.3 C4 No Malaria, Tp 
70,000
+  – – Suspected concurrent 
infection
11/1982 Pv 0.25 C4 No Malaria +  – – Suspected concurrent 
infection
12/1979 Pf 0.4 C4 Yes¶ Malaria +  – – Suspected concurrent 
infection
13/1956 Pv 0.5 C4 Yes# Malaria, Tp 
63,000, Hb 5.9, 
Sat 83%
+ – – Suspected concurrent 
infection
14/1976 Pv 0.7 C4 No Malaria + – – Suspected concurrent 
infection
15/1988 Pv 0.5 C4 No Malaria, Tp 
29,000, BP 90/50
+ – – Suspected concurrent 
infection
16/1974 Pv 0.1 C3 No Malaria, HR 146 
bpm
+ – – Suspected concurrent 
infection
17/1961 Pv <0.1 C2 No Malaria‡ + – – Suspected concurrent 
infection
*IgM, immunoglobulin M; RT-PCR, reverse transcription–PCR; Iso, isolate; Pv, Plasmodium vivax; – , negative; +, positive; DEN, dengue; ND, not done; 
Pf, P. falciparum; Tp, thrombocytopenia++ (<100,000 platelets/μL); Hb, hemoglobin (reference range <10 g/L); BP, arterial blood pressure 
(systolic/diastolic); Sat, blood oxygen saturation; HR, heart rate; bpm, beats per minute.  
†Hospitalization >8 hours. 
‡Possible asymptomatic carrier of Plasmodium spp. 
§For diabetes requiring insulin. 
¶For treatment with Riamet (arthemether + lumefantrine). 
#For interstitial pneumonia. the third because treatment with Riamet (arthemether + 
lumefantrine) was only available to inpatients.
Conclusions 
Malaria and dengue must be suspected in febrile pa-
tients living in or returning from areas endemic for these 
infections. Although the usual places of contamination by 
malaria and dengue viruses are quite different in French 
Guiana, considering that the incubation phase is longer for 
malaria than for dengue and that the population’s mobility 
is high, a simultaneous clinical expression of the 2 diseases 
is plausible. Moreover, in French Guiana, dengue viruses 
have spread to malaria-endemic rural areas (9).  
The conﬁ  rmation of malaria is rapid, and after malaria 
is conﬁ  rmed, dengue is usually ruled out without screening 
for it. Two methods can conﬁ  rm dengue: dengue-speciﬁ  c 
IgM seroconversion or detection of dengue virus particles 
during the acute phase (day 0 to day 4 after onset of fever) 
by RT-PCR, which is faster and more speciﬁ  c. In published 
case reports (1–7), the diagnosis of dengue infection is usu-
ally made based on positive dengue IgM; however, this 
cannot conﬁ  rm recent dengue, because IgM can persist for 
months and cross-react with other arboviruses (10). If RT-
PCR requires a speciﬁ  c laboratory and cannot be performed 
on site, a new test, the Platelia, is now easily included in 
any laboratory and is indicated particularly for early-acute 
phase samples (11). To investigate the frequency of dengue 
and malaria co-infection, the Platelia test should be used 
in all cases of dengue-like or malaria-like syndrome, even 
when malaria diagnosis was positive, in regions where both 
infections may overlap.
Of the 1,723 patients investigated in this study, 17 had 
concurrent dengue and malaria. In 10 of these patients, re-
cent acute dengue fever could not be conﬁ  rmed (LDC). Two 
patients, 1 of whom was part of the EDC group, could have 
been asymptomatic carriers of Plasmodium spp. (1 patient 
with P. falciparum and 1 with P. vivax) because of low 
parasitemia (12). A true acute concurrent infection (strictly 
deﬁ  ned diagnosis) was conﬁ  rmed in 6 case-patients. Con-
current acute malaria and recent dengue fever had a lower 
frequency than predicted by the multiplication of both prev-
alences, but such reasoning implies the same overlapping 
contamination areas for malaria and dengue, which it is not 
the situation in French Guiana. The greater prevalence of 
LDC than EDC associated with acute malaria infection il-
lustrates the prolonged persistence of speciﬁ  c IgM or IgM 
cross-reaction, which increases the probability of a malaria 
case when comparing the short 4–5 day period correspond-
ing to EDC. Virologic investigations using isolation or RT-
PCR techniques were not performed on samples taken after 
the 4th day because of the usual disappearance of viremia. 
Additional associations where fever was initially caused by 
malaria and followed by dengue after the 4th day of malaria 
fever could have been undiagnosed.
EDC were diagnosed on average after 4 days of fever, 
never 5. Thus, delayed complications of dengue or malaria 
may not be detected using this deﬁ  nition. Such complica-
tions could be observed in patients considered LDC. One 
of these patients had pneumonia, which has recently been 
described as a complication of P. vivax (13). 
Although acute concurrent infections were benign in 
our study, special attention should be given to the possibili-
ty of co-infection with malaria and dengue, especially when 
P. falciparum is implicated. The distinction between severe 
dengue and severe malaria must be made in an emergency 
department or hospital setting because in both situations, 
early diagnosis is essential for patient care.  
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